Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Lactoferrin  COVID-19 treatment studies for Lactoferrin  C19 studies: Lactoferrin  Lactoferrin   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
Lactoferrin Inhibition of the Complex Formation between ACE2 Receptor and SARS CoV-2 Recognition Binding Domain
Piacentini et al., International Journal of Molecular Sciences, doi:10.3390/ijms23105436 (In Vitro)
Piacentini et al., Lactoferrin Inhibition of the Complex Formation between ACE2 Receptor and SARS CoV-2 Recognition Binding.., International Journal of Molecular Sciences, doi:10.3390/ijms23105436 (In Vitro)
May 2022   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Biolayer interferometry and turbidimetry study showing lactoferrin inhibits ACE2 - SARS-CoV-2 RBD binding.
Piacentini et al., 13 May 2022, Italy, peer-reviewed, 10 authors.
Contact: giacomo.parisi@iit.it (corresponding author), roberta.piacentini@uniroma1.it, centi.laura95@gmail.com, alberto.boffi@uniroma1.it, miottomattia1@gmail.com, edoardo.milanetti@uniroma1.it, lorenzo.dirienzo@iit.it, martina.pitea@iit.it, giancarlo.ruocco@iit.it, paolopiazza@edifinstruments.com.
In Vitro studies are an important part of preclinical research, however results may be very different in vivo.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperLactoferrinAll
Abstract: International Journal of Molecular Sciences Article Lactoferrin Inhibition of the Complex Formation between ACE2 Receptor and SARS CoV-2 Recognition Binding Domain Roberta Piacentini 1,2 , Laura Centi 1 , Mattia Miotto 2,3 , Edoardo Milanetti 2,3 , Lorenzo Di Rienzo 2 , Martina Pitea 2,4 , Paolo Piazza 5 , Giancarlo Ruocco 2,3 , Alberto Boffi 1 and Giacomo Parisi 2, * 1 2 3 4 5 * Citation: Piacentini, R.; Centi, L.; Miotto, M.; Milanetti, E.; Di Rienzo, L.; Pitea, M.; Piazza, P.; Ruocco, G.; Boffi, A.; Parisi, G. Lactoferrin Department of Biochemistry, Sapienza University, Piazzale Aldo Moro 5, 00185 Rome, Italy; roberta.piacentini@uniroma1.it (R.P.); centi.laura95@gmail.com (L.C.); alberto.boffi@uniroma1.it (A.B.) Center of Life Nano and Neuro Science, Institute of Italian Technology, Viale Regina Elena 291, 00181 Rome, Italy; miottomattia1@gmail.com (M.M.); edoardo.milanetti@uniroma1.it (E.M.); lorenzo.dirienzo@iit.it (L.D.R.); martina.pitea@iit.it (M.P.); giancarlo.ruocco@iit.it (G.R.) Department of Physics, Sapienza University, Piazzale Aldo Moro 5, 00185 Rome, Italy D-Tails s.r.l., Via di Torre Rossa 66, 00165 Rome, Italy EDIF Instruments s.r.l., Via Ardeatina 132, 00147 Rome, Italy; paolopiazza@edifinstruments.com Correspondence: giacomo.parisi@iit.it Abstract: The present investigation focuses on the analysis of the interactions among human lactoferrin (LF), SARS-CoV-2 receptor-binding domain (RBD) and human angiotensin-converting enzyme 2 (ACE2) receptor in order to assess possible mutual interactions that could provide a molecular basis of the reported preventative effect of lactoferrin against CoV-2 infection. In particular, kinetic and thermodynamic parameters for the pairwise interactions among the three proteins were measured via two independent techniques, biolayer interferometry and latex nanoparticle-enhanced turbidimetry. The results obtained clearly indicate that LF is able to bind the ACE2 receptor ectodomain with significantly high affinity, whereas no binding to the RBD was observed up to the maximum “physiological” lactoferrin concentration range. Lactoferrin, above 1 µM concentration, thus appears to directly interfere with RBD–ACE2 binding, bringing about a measurable, up to 300-fold increase of the KD value relative to RBD–ACE2 complex formation. Inhibition of the Complex Formation between ACE2 Receptor and SARS CoV-2 Recognition Binding Domain. Keywords: SARS-CoV-2 receptor-binding domain (RBD); angiotensin-converting enzyme 2 (ACE2); lactoferrin; biolayer interferometry; nanoparticle enhanced turbidimetry; kinetic analysis Int. J. Mol. Sci. 2022, 23, 5436. https://doi.org/10.3390/ijms23105436 Academic Editor: Samuel De Visser Received: 20 April 2022 Accepted: 11 May 2022 Published: 13 May 2022 Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. Copyright: © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit